The world faces a worsening crisis in health care: a growing number of bacteria resistant to existing antibiotics. But
There are some new antibiotics in development to take place this increasingly ineffective drugs. We view
number of proposals aimed at strengthening the development of drugs, including financial incentives for pharmaceutical manufacturers >> << as an extension of effective patent life for new antibiotics. However, such strategies directly conflict with a clear >> << need to reduce unnecessary antibiotic treatment and may actually increase prescription use. As an alternative we recommend
with two prongs, BЂњintegratedBЂ "strategy. This will increase the recoverability scientifically based use of antibiotics
, which also met specific health goalsBЂ "such as cheap strattera reducing disease, while limiting the resistance to antibiotics. .
No comments:
Post a Comment